Correlation Between Tarsus Pharmaceuticals and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Emergent Biosolutions, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Emergent Biosolutions.
Diversification Opportunities for Tarsus Pharmaceuticals and Emergent Biosolutions
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tarsus and Emergent is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Emergent Biosolutions
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.75 times more return on investment than Emergent Biosolutions. However, Tarsus Pharmaceuticals is 1.33 times less risky than Emergent Biosolutions. It trades about -0.27 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about -0.47 per unit of risk. If you would invest 5,145 in Tarsus Pharmaceuticals on November 28, 2024 and sell it today you would lose (889.00) from holding Tarsus Pharmaceuticals or give up 17.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Emergent Biosolutions
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Emergent Biosolutions |
Tarsus Pharmaceuticals and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Emergent Biosolutions
The main advantage of trading using opposite Tarsus Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges |